AIM
BPTH

Acrospire Investment Management’s Bio-Path Holdings Inc BPTH Stock Holding History

Acrospire Investment Management’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2
Closed -$17K – 2206
2016
Q2 		$17K Buy
+2
New +$20.3K 0.01% 1589

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrospire Investment Management's BPTH Position: Q3 2016 in Review

Acrospire Investment Management sold out of Bio-Path Holdings Inc (BPTH) in Q3 2016, closing a stake of 2 shares — an estimated $17K sold.

Acrospire Investment Management first reported a position in BPTH in Q2 2016 and held it in 1 quarter. The position peaked at $17K in Q2 2016. 43 funds tracked by Wall St. Rank hold BPTH as of Q3 2016.

  • Acrospire Investment Management reported no remaining Bio-Path Holdings Inc position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 2 Bio-Path Holdings Inc shares in Q3 2016, an estimated $17K.
  • Acrospire Investment Management first reported a position in Bio-Path Holdings Inc in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Bio-Path Holdings Inc position peaked at $17K in Q2 2016.
  • 43 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.